ClinicalTrials.gg
Active, not recruitingNCT06407648Updated Oct 9, 2026

Using Personalized Assessments in the Treatment of Childhood OCD

An interventional study of Personalized Assessments and Standard of Care in Obsessive-Compulsive Disorder, sponsored by Johns Hopkins University. Active, not recruiting at 1 site in United States. Open to participants aged 8 Years to 17 Years. Per ClinicalTrials.gov, last updated 2026-10-09.

Sponsored by Johns Hopkins University · Not applicable, Interventional, and Treatment

How we know

Updated Oct 9, 2026Primary completion movedGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
8 Years to 17 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 299 studies in Obsessive-Compulsive Disorder with a site in United States — 59 open to participants now, 77 under way, 2 of them phase 3. Obsessive-Compulsive Disorder · United States.

Planned enrollment
142nd of 246
30 · median 40
Started
2024
with 12 others
No phase
144 of 299
34 open now
Primary completion
2026-09
later than 11 of 76 live
Registered
267th of 299
by date

Among the 299 studies in Obsessive-Compulsive Disorder with a site in United States, this one is the 142nd largest by planned enrollment of the 246 interventional ones that give a count, is one of 13 that started in 2024, is one of 144 with no phase, reaches primary completion later than 11 of the 76 other live ones, and was the 267th registered.

Obsessive-Compulsive Disorder

637 studies on the registry are indexed under Obsessive-Compulsive Disorder; 167 are open to participants now.

Browse Obsessive-Compulsive Disorder studies →

Open to participants now

59 of the 299 studies in Obsessive-Compulsive Disorder with a site in United States are open now. Recruiting first, the newest first:

54 more — sign in →

All 59 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 120 Obsessive-Compulsive Disorder studies recruiting now, 30 (25%) set no upper age limit and 82 (68%) stop at 75 or younger; 28 take children under 18; 19 take healthy volunteers.

This study: 8 Years to 17 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 299 studies in Obsessive-Compulsive Disorder with a site in United States, or all of them as a file.
02

Study summary

The primary purpose of this study is to learn whether personalized assessment of obsessive-compulsive disorder (OCD) symptoms in childhood OCD using mobile health technology are feasible and acceptable for youth and parents. The investigators will also examine whether personalized cognitive-behavioral therapy (CBT) that is informed by personalized OCD assessments yields better clinical outcomes when compared to standard CBT for youth with OCD

03

Conditions studied

  • Obsessive-Compulsive Disorder

Keywords

  • children
  • adolescents
  • exposure with response prevention
  • cognitive behavioral therapy
  • ERP
  • CBT
04

Who can participate

Ages eligible
8 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. be 8-17 years of age;
  2. meet diagnostic criteria for a primary diagnosis of OCD on a structured clinical interview;
  3. have moderate OCD severity as evidenced by a CY-BOCS total score of ≥16;
  4. medication free and/or on a stable dose of medication 8 weeks prior to study participation;
  5. be English speaking.

Exclusion criteria

Exclusion Criteria:

  1. the presence of psychotic disorder, bipolar disorder, or autism spectrum disorders;
  2. significant suicidal ideation that warrants medical intervention;
  3. concurrent psychotherapy for OCD;
  4. inability to complete scales, or attend visits.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Personalized Assessments

    12 sessions of exposure with response prevention (ERP) that is guided by personalized assessments.

    Other: Personalized Assessments

  • Active comparator
    Standard of Care

    12 sessions of exposure with response prevention (ERP) that is guided using standard practice.

    Other: Standard of Care

Interventions

  • OtherPersonalized Assessments

    Personalized CBT will use individualized OCD symptom networks to guide CBT strategies to target central symptom nodes in contemporaneous networks.

  • OtherStandard of Care

    The standard CBT condition will use standard-of-care approaches to guide CBT strategies to target OCD symptoms.

06

What researchers measure

Primary outcomes

  1. Children's Yale-Brown Obsessive-Compulsive Scale Second Edition (CY-BOCS-II) Total Severity Score

    A clinician-rated measure of OCD symptom severity in the past week. This 10-item measure is rated on a 0 to 5 scale with a total score ranging from 0 to 50. A higher total score is reflective of greater OCD symptom severity.

    Time frame: Screen, Baseline (Week 0), Week 4, Week 8, and Week 12

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Apr 2024 to primary completion in Sep 2026, 29 months.

Of 235 non-industry interventional studies with no phase under Obsessive-Compulsive Disorder, half reached primary completion within 43 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 63. This study's 29 months is below that.

Counting every sponsor, half of 238 studies reached it within 43 months; a quarter within 22 and three quarters within 63.

How these figures are worked out, and which studies are left out of them.

Registered
May 6, 2024
First posted
May 9, 2024
StartActual
Apr 3, 2024
Primary completionActual
Sep 15, 2026
CompletionEst.
Dec 30, 2026
Last update
Oct 9, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Primary completion
Sep 30, 2026→Sep 15, 2026 (actual)
Oct 9, 2026
Show all 1 update
  1. Oct 9, 2026
    Primary completion Sep 30, 2026→Sep 15, 2026 (now actual)
    + 1 other change: verification date

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06407648
Responsible party
Sponsor
First posted
May 9, 2024
Start date
Apr 3, 2024
Primary completion
Sep 15, 2026
Completion
Dec 30, 2026 (estimated)
Last update
Oct 9, 2026

Study contacts

Joseph F. McGuire, PhD
principal investigator · Johns Hopkins University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion